Amitriptyline: Useful for the prophylactic treatment of migraine?
Keywords:Amitriptyline; Migraine; Treatment.
Migraine is a type of headache described by recurrent attacks that may be accompanied by some symptoms, such as nausea, vomiting, phonophobia, among other conditions. About 1 billion people in the world could come into existence. Some measurements are recognized for the treatment of use, as measurements are made appropriately with cost drugs. Amitriptyline has become a great alternative for the prophylactic treatment of migraine, its metabolization is extensively in the liver and its analgesic effect is linked to the ability to modulate mood or modulate the excitability of neurons that transmit pain signals from the dura mater. This study is an integrative literature review. A search key was created, and the search was performed in the Web of Science (WoS-all databases). A temporal search was carried out between the years 2018 to June 2022, without language restriction. Tools such as MapChart were used to create the worldwide distribution map based on the corresponding author. 100 articles were rescued from the Web of Science, of which only 20 were chosen to compose the final table, due to their high relevance and sensitivity in the investigated topic. Migraine prevention for patients is critical, as it can reduce stigma and enhance quality of life.
Arruda, M. A., Chevis, C. F., & Bigal, M. E. (2018). Recent advances in the management of chronic migraine in children. Expert Review of Neurotherapeutics, 18(3), 231-239.
Becker, W. J. (2015). Acute migraine treatment in adults. Headache: The Journal of Head and Face Pain, 55(6), 778-793.
Bruno, M. A., & Krymchantowski, A. V. (2018). Amitriptyline and intraoral devices for migraine prevention: a randomized comparative trial. Arquivos de Neuro-Psiquiatria, 76, 213-218.
Bryson, H. M., & Wilde, M. I. (1996). Amitriptyline. Drugs & aging, 8(6), 459-476.
Burch, R. (2019). Antidepressants for preventive treatment of migraine. Current treatment options in neurology, 21(4), 1-12.
Burch, R. (2019). Headache in Pregnancy and the Puerperium. Neurologic Clinics, 37(1), 31-51.
Centro Nacional de Informações de Biotecnologia (2022). Resumo do Composto pubchem para CID 11065, cloridrato de amitriptilina. Recuperado em 12 de julho de 2022 de https://pubchem.ncbi.nlm.nih.gov/compound/11065.
Couch, J. R., & Amitriptyline Versus Placebo Study Group. (2011). Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache: The Journal of Head and Face Pain, 51(1), 33-51.
Couch, J. R., & Hassanein, R. S. (1979). Amitriptyline in migraine prophylaxis. Archives of Neurology, 36(11), 695-699.
Fallah, R., Fazelishoroki, F., & Sekhavat, L. (2018). A randomized clinical trial comparing the efficacy of melatonin and amitriptyline in migraine prophylaxis of children. Iranian journal of child neurology, 12(1), 47.
Gomersall, J. D., & Stuart, A. (1973). Amitriptyline in migraine prophylaxis: changes in pattern of attacks during a controlled clinical trial. Journal of Neurology, Neurosurgery & Psychiatry, 36(4), 684-690.
Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002). Migraine—current understanding and treatment. New England journal of medicine, 346(4), 257-270.
Hmoud, M., Al-Husayni, F., Alzahrani, A., Alharthi, A., & Alwafi, E. (2021). Hypertension Secondary to Amitriptyline Use as Prophylactic for Migraine in a 26-Year-Old Man. Cureus, 13(1).
Im, H. J., & Cho, S. J. (2020). Pharmacotherapy of migraine prevention based on the assessment of headache. Journal of the Korean Medical Association, 63(10), 644-649.
Kacperski, J., Green, A., & Qaiser, S. (2020). Management of chronic migraine in children and adolescents: a brief discussion on preventive therapies. Pediatric Drugs, 22(6), 635-643.
Kang, I. S., Cho, J. H., Lee, M. G., & Jang, I. S. (2018). Modulation of tetrodotoxin-resistant Na+ channels by amitriptyline in dural afferent neurons. European Journal of Pharmacology, 838, 69-77.
Khrizman, M., & Pakalnis, A. (2018). Management of pediatric migraine: current therapies. Pediatric Annals, 47(2), e55-e60.
Mendes, K. D. S., Silveira, R. C. C. P., & Galvão, C. M. (2019). Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão interativa. Revista Texto e Contexto Enfermagem, 28 (1): e20170204.
Mo, T., Mo, M. C., & Mo, S. P. O. (2021). A comparison between amitriptyline and divalproex in prophylactic treatment of episodic migraine: An open label study from Nepal. Neurology Asia, 26(1), 107-112.
Moore, R. A., Derry, S., Aldington, D., Cole, P., & Wiffen, P. J. (2012). Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews, (12).
Naito, Y., Ishii, M., Ishibashi, M., Kasai, H., & Katoh, H. (2018). Negative predictors of clinical response to amitriptyline in Japanese patients with migraine. Neurology and Clinical Neuroscience, 6(5), 125-130.
Obata, H. (2017). Analgesic mechanisms of antidepressants for neuropathic pain. International journal of molecular sciences, 18(11), 2483.
Olla, D., Sawyer, J., Sommer, N., & Moore, J. B. (2020). Migraine treatment. Clinics in plastic surgery, 47(2), 295-303.
Oskoui, M., Pringsheim, T., Billinghurst, L., Potrebic, S., Gersz, E. M., Gloss, D., ... & Hershey, A. D. (2019). Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology, 93(11), 500-509.
Qureshi, M. H., Esper, G. J., & Bashir, F. F. (2019). When to consider prophylactic antimigraine therapy in children with migraine. Current Treatment Options in Neurology, 21(4), 1-7.
Rao, R., & Hershey, A. D. (2020). An update on acute and preventive treatments for migraine in children and adolescents. Expert Review of Neurotherapeutics, 20(10), 1017-1027.
Reidy, B. L., Peugh, J., Hershey, A. D., Coffey, C. S., Chamberlin, L. A., Ecklund, D. J., ... & Powers, S. W. (2022). Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial. Cephalalgia, 42(1), 44-52.
Rettig, E. K., Ergun, G., Warfield, J. R., Slater, S. K., LeCates, S. L., Kabbouche, M. A., ... & Powers, S. W. (2022). Predictors of improvement in pediatric chronic migraine: results from the cognitive-behavioral therapy and amitriptyline trial. Journal of Clinical Psychology in Medical Settings, 29(1), 113-119.
Santos, C., & Weaver, D. F. (2018). Topically applied linoleic/linolenic acid for chronic migraine. Journal of Clinical Neuroscience, 58, 200-201.
Schneider, J., Patterson, M., & Jimenez, X. F. (2019). Beyond depression: Other uses for tricyclic antidepressants. Cleveland Clinic Journal of Medicine, 86(12), 807-814.
Silberstein, S. D. (2009). Preventive migraine treatment. Neurologic clinics, 27(2), 429-443.
Silberstein, S. D. (2015). Preventive migraine treatment. Continuum: Lifelong Learning in Neurology, 21(4 Headache), 973.
Thour, A., & Marwaha, R. (2019). Amitriptyline.
Tripathi, G. M., Kalita, J., & Misra, U. K. (2018). A study of oxidative stress in migraine with special reference to prophylactic therapy. International Journal of Neuroscience, 128(4), 318-324.
Torraco, R. J. (2005). Writing integrative literature reviews: Guidelines and examples. Human resource development review, 4(3), 356-367.
Torraco, R. J. (2016). Writing integrative reviews of the literature: Methods and purposes. International Journal of Adult Vocational Education and Technology (IJAVET), 7(3), 62-70.
Von Brevern, M., & Lempert, T. (2020, February). Vestibular migraine: treatment and prognosis. In Seminars in Neurology (Vol. 40, No. 01, pp. 083-086). Thieme Medical Publishers.
Whittemore, R., & Knafl, K. (2005). The integrative review: updated methodology. Journal of advanced nursing, 52(5), 546-553.
How to Cite
Copyright (c) 2022 Cristian dos Santos Pereira; Joelson Rodrigues Farias; Paulo Roberto Peres Machado; Glenda Luciana Costa Braga; Maria Cláudia Pinheiro Corôa; Rafaela Marques Ribeiro; Taissa Viana Damasceno; Maria Rosinete Siqueira Picanço; Allan Carlos da Silva Tiago; Everton Luiz Pompeu Varela
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.